NIH-funded research R21 grant

How sickle cell trait affects brain health and cognitive function in older adults

Official title: Interaction of sickle cell trait with human apolipoprotein E ε4: Impact on brain structure, brain lipidomics, neuroinflammation and cognitive deficit

Funded at University of Cincinnati · NIH-10993275 · Data updated 2026-11-12

This study is looking at how having sickle cell trait might affect brain health, especially in older African Americans, by exploring its connection with a gene linked to Alzheimer's disease, and it involves brain scans and memory tests to better understand these effects.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Cincinnati
NIH-funded
Lab location1 site (Cincinnati, United States)
Project startSeptember 1, 2024
Project endAugust 31, 2026
Funding year2024
Award (this year)$445,500
NIH project number1R21AG089843-01
Project IDNIH-10993275 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are older adults aged 65 and above, particularly those of African ancestry who carry the sickle cell trait.

Less likely to help

Patients who do not have sickle cell trait or are under the age of 65 may not benefit from this research.

What this research studies

This research investigates the relationship between sickle cell trait and brain health, particularly focusing on how it interacts with a specific gene variant (apolipoprotein E ε4) that is linked to Alzheimer's disease and related dementias. The study aims to understand how these factors influence brain structure, lipid composition, neuroinflammation, and cognitive deficits in older adults, especially within the African American population. By analyzing brain imaging and lipid profiles, the research seeks to uncover potential biological mechanisms that contribute to cognitive decline. Participants may undergo assessments that include brain scans and cognitive tests to gather data on these interactions.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and targeted interventions for cognitive decline in older adults with sickle cell trait.

How similar studies have gone: While the interaction of sickle cell trait and cognitive decline is a relatively novel area of investigation, previous studies have shown that genetic factors can significantly influence dementia risk, suggesting potential for impactful findings.

Where this research is happening

  • University of Cincinnati
    Cincinnati, United States
    Active

Researchers

  • Principal investigator: Hyacinth, Hyacinth Idu — University of Cincinnati
  • Study coordinator: Hyacinth, Hyacinth Idu

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.